CL.CN - Cresco Labs Inc.

Canadian Sec - Canadian Sec Delayed Price. Currency in CAD
7.91
+0.82 (+11.57%)
At close: 3:59PM EDT
Stock chart is not supported by your current browser
Previous Close7.09
Open0.00
Bid7.68 x 0
Ask7.91 x 0
Day's Range0.00 - 0.00
52 Week Range
Volume0
Avg. Volume290,740
Market Cap884.757M
Beta (3Y Monthly)-3.36
PE Ratio (TTM)N/A
EPS (TTM)-0.14
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • OTC Markets Group & Canadian Securities Exchange to Cohost Cannabis Investor Day at OTC Markets Group's 300 Vesey Street NY Headquarters
    PR Newswire

    OTC Markets Group & Canadian Securities Exchange to Cohost Cannabis Investor Day at OTC Markets Group's 300 Vesey Street NY Headquarters

    Investors, Entrepreneurs and Publicly-Traded Cannabis Companies Convene to Discuss the Current State of the Cannabis Industry NEW YORK , Oct. 15, 2019 /PRNewswire/ -- OTC Markets Group Inc. (OTCQX: OTCM), ...

  • CNW Group

    Jushi Holdings Inc. Announces Closing Of Sale Of Its Minority Stake In Gloucester Street Capital For Cash And Equity

    BOCA RATON, Fla. , Oct. 10, 2019 /PRNewswire/ -- Jushi Holdings Inc. ("Jushi" or the "Company") (NEO:JUSH.B) (OTCQX:JUSHF), a globally-focused, multi-state cannabis and hemp operator, today announced the closing of the sale of its 16.5% ownership interest in Gloucester Street Capital (" Gloucester "), the parent company of Valley Agriceuticals and owner of one of ten New York licensed medical cannabis operators. Jushi previously purchased its 16.5% interest in Gloucester in February 2018 for US$5 million in cash. The sale is part of the Cresco Labs Inc.'s (CL.CN) (CRLBF) acquisition of Gloucester .

  • Business Wire

    Cresco Labs Announces Closing of Acquisition in New York State

    Cresco Labs Inc. (“Cresco Labs” or the “Company”) (CL.CN) (CRLBF), one of the largest vertically integrated multistate cannabis operators in the United States, today announced that it has closed its acquisition of 100% of the membership interests of Gloucester Street Capital, LLC (“Gloucester”), the parent entity of Valley Agriceuticals, LLC ("Valley Ag") via a merger between Gloucester and a subsidiary of Cresco Labs. As a result of this acquisition, Cresco Labs now holds one of the 10 vertically integrated cannabis business licenses granted in the State of New York by the New York State Department of Health.

  • Business Wire

    Cresco Labs Receives First Adult-Use Cultivation Approvals Granted in Illinois

    Cresco Labs Inc. (“Cresco Labs” or the “Company”) (CL.CN) (CRLBF), one of the largest vertically integrated multistate cannabis operators in the United States, today announced that its three cultivation facilities in the state of Illinois have been approved for growing adult-use cannabis by the Illinois Department of Agriculture. The three facilities, located in Joliet, Kankakee and Lincoln, can represent a total combined cultivation space at completion of 630,000 square feet per Illinois state regulations. “We are very pleased to receive the first adult-use cultivation approvals granted in Illinois, which speaks to our continued success in efficiently executing on our strategic priorities,” said Cresco Labs CEO and Co-founder Charlie Bachtell.

  • Business Wire

    Cresco Labs Enters Into Sale-and-Leaseback Agreement With Innovative Industrial Properties for Illinois Facilities

    Cresco Labs Inc. (“Cresco Labs” or the “Company”) (CL.CN) (CRLBF), one of the largest vertically integrated multistate cannabis operators in the United States, today announced that it has signed a binding agreement to sell its Joliet and Kankakee, Illinois properties to Innovative Industrial Properties, Inc. (“IIP”) for approximately $46.3 million, which amount includes funding for additional tenant improvements at the Kankakee property. Concurrent with the closing of the sale, Cresco Labs will enter into a long-term, triple-net lease agreement with IIP and will continue to operate each property as a licensed cannabis cultivation and processing facility. “This sale-and-leaseback agreement with IIP represents a non-dilutive capital solution for Cresco Labs that will support the expansion of our Illinois operations in preparation for the legalization of adult-use cannabis on January 1, 2020,” said Cresco Labs CEO and Co-founder Charlie Bachtell.

  • Business Wire

    Cresco Labs Comments on the Passage of the Safe Banking Act in the U.S. House of Representatives

    “The passage of the SAFE Banking Act by the U.S. House of Representatives represents a significant first step in the effort to provide stability and security to the multibillion-dollar cannabis industry,” said Cresco Labs CEO and Co-founder Charlie Bachtell. The passage of the SAFE Banking Act will also provide access to banking and capital to fuel diversity and make the cannabis industry more inclusive for everyone.

  • Business Wire

    NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE U.S. Cresco Labs Announces Closing of C$73.5 Million Underwritten Public Unit Offering

    Cresco Labs Inc. (“Cresco Labs” or the “Company”) (CL.CN) (CRLBF), one of the largest vertically integrated multistate cannabis operators in the United States, is pleased to announce the closing today of its previously announced public offering (the "Offering"). Pursuant to the Offering, the Company issued 7,350,000 units (the "Units") at a price per Unit of C$10.00 (the "Offering Price"), for gross proceeds of C$73,500,000. The Offering was conducted by a syndicate of underwriters, led by Canaccord Genuity Corp., and including Beacon Securities Limited, Cormark Securities Inc., Eight Capital and GMP Securities L.P..

  • Business Wire

    Cresco Labs and Origin House Announce Substantial Compliance with HSR Second Request

    Cresco Labs Inc. (“Cresco Labs”) (CL.CN) (CRLBF) and CannaRoyalty Corp. d/b/a Origin House (“Origin House” and together with Cresco Labs, the “Companies” – CSE: OH, OTCQX: ORHOF), both announced today that, effective September 16, 2019, they have each submitted certifications of substantial compliance with the request for additional information (“Second Request”) from the United States Department of Justice Antitrust Division (the “DOJ”) in connection with Origin House’s and Cresco Labs’ notification to U.S. antitrust authorities pursuant to the Hart-Scott-Rodino Antitrust Improvements Act of 1976 (“HSR Act”), as amended, in respect of Cresco Labs’ pending acquisition of Origin House (the “Transaction”).

  • Business Wire

    Cresco Labs to Acquire Tryke Including the Reef Dispensary Portfolio – Consistent With Stated Plan to Establish Market Leading Positions in Both Nevada and Arizona and Build Brand and Wholesale Capabilities

    Tryke generated US$70.4 million in Revenue and US$24.6 million in EBITDA in fiscal 20181, making it one of the highest grossing and most profitable private cannabis companies in the U.S. market. Arizona is one of the largest and fastest growing medical-only markets with estimated 2019 sales of up to US$760 million 2 . Tryke has established six of the best-positioned retail locations in Nevada and Arizona, including the iconic Reef Dispensary located adjacent to the Las Vegas Strip and five additional operating locations in North Las Vegas, Sparks and Phoenix, AZ.

  • CNW Group

    Cresco Labs to Acquire Tryke Companies Including the Reef Dispensary Portfolio - Consistent With Stated Plan to Establish Market Leading Positions in Both Nevada and Arizona and Build Brand and Wholesale Capabilities

    Tryke generated US$70.4 million in Revenue and US$24.6 million in EBITDA in fiscal 20181, making it one of the highest grossing and most profitable private cannabis companies in the U.S. market. Arizona is one of the largest and fastest growing medical-only markets with estimated 2019 sales of up to US$760 million 2. Tryke has established six of the best-positioned retail locations in Nevada and Arizona , including the iconic Reef Dispensary located adjacent to the Las Vegas Strip –  which has produced over US$65 million in revenue since 2015 – and five additional operating locations in North Las Vegas , Sparks and Phoenix, AZ.

  • MarketWatch

    Cowen is bullish marijuana companies with CPG model, bearish on MedMen given retail reliance

    Cowen analyst Vivien Azer initiated coverage Friday of five multi-state cannabis operators, saying she's bullish on those that rely on the consumer packaged goods model given the higher margins, especially relative to those relying on the retail model. Azer started Green Thumb Industries Inc. at outperform with a stock price target of $18.50, Curaleaf Holdings Inc. at outperform with a $10.50 target, and Cresco Labs Inc. at outperform with a $14 target. "We believe that the greatest shareholder value will be created through businesses that emulate a traditional CPG finished goods model, given its superior margin structure," Azer wrote in a note to clients. Meanwhile, Azer started MedMen Enterprises Inc. at underperform with a $1.50 price target. "[MedMen] is the clear leader in the [California] market, with a distinguished brand, reflecting an attractive retail concept," Azer wrote. "However, to us, retail is less attractive than wholesale. And, an over-reliance on retail revenues today, coupled with excessive spending and notable management turnover, make this a'show-me' story." Azer also started Acreage Holdings Inc. at market perform with a $9 target, saying consolidation a of a "disparate network of dispensaries" and launching a "nascent brand strategy" could prove challenging. The ETFMG Alternative Harvest ETF was up 0.4% in afternoon trading, but has lost 28.7% over the past three months, while the S&P 500 has gained 3.5% in three months.

  • These U.S. Pot Stocks Are a Bargain, According to This 69-Year-Old Investment Bank
    Motley Fool

    These U.S. Pot Stocks Are a Bargain, According to This 69-Year-Old Investment Bank

    Three vertically integrated multistate operators look attractive to Canaccord Genuity.

  • These 3 States Will Begin Selling Recreational Pot Fairly Soon
    Motley Fool

    These 3 States Will Begin Selling Recreational Pot Fairly Soon

    Two of these three states should be billion-dollar cannabis markets by 2024.

  • Why Cresco Labs Could Be an Underrated Stock to Buy Today
    Motley Fool

    Why Cresco Labs Could Be an Underrated Stock to Buy Today

    Despite the industry's latest woes, there are still some good deals for cannabis investors.

  • Newsfile

    Pre-Earnings Review of Cresco's Operations - Interview with Cresco Labs President Joe Caltabiano

    Toronto, Ontario--(Newsfile Corp. - August 20, 2019) - Capital 10X sits down with Cresco Labs (CNSX: CL) President Joe Caltabiano for a pre-earnings review of the multi-state operator's expansion.Cannot view this video? Visit:https://capital10x.com/interview-cresco-labs-joe-caltabiano-pre-earnings-review/Joe talks about the recent Sunnyside* retail rollout, current and future acquisitions, and Cresco Labs' strategy as they continue to grow into one of top U.S. cannabis companies.For more information, please contact:Capital 10XEvan Veryard, President416-571-9037To view the source version of ...